Ukko

Ukko
Ukko is developing novel food allergy and disorder treatments using advanced immunology and plant science.
About
Technology stack
detected 2026-07-02No comments yet. Be the first to share your take.
What does Ukko do?
Ukko is dedicated to improving the lives of individuals suffering from food allergies and disorders. They leverage cutting-edge technologies in immunology, computational biology, and plant science to create innovative therapeutic approaches. The company has a presence in Tel Aviv, Israel, and Palo Alto, California.
How much funding has Ukko raised?
Ukko has raised a total of $40M in funding. The most recent round on record is Series B.
Where is Ukko headquartered?
Ukko is headquartered in Palo Alto, United States.
When was Ukko founded?
Ukko was founded in 2016.
What industry does Ukko operate in?
Ukko operates in Healthcare, Allergen, Immunology, Celiac, Genomics, HealthTech.
How many employees does Ukko have?
Ukko has approximately 58 people on record.
What is Ukko's revenue?
StartupHub estimates Ukko's annual revenue at $19.1M (range $10.1M to $30.4M, 63% confidence), based on comparable companies in the sector.
What is Ukko's valuation?
StartupHub estimates Ukko's effective valuation at $170.4M (range $100.0M to $240.0M, 10% confidence), based on comparable companies in the sector.
